Related references
Note: Only part of the references are listed.Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency Department
Marilena Minieri et al.
DIAGNOSTICS (2022)
Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study
Natalie J. Atallah et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia
Aleksandr A. A. Astapovskii et al.
FRONTIERS IN MEDICINE (2022)
The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study
Claudia Gregoriano et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
High value of mid-regional proadrenomedullin in COVID-19: A marker of widespread endothelial damage, disease severity, and mortality
Silvia Spoto et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
SARS-CoV-2: Comparative analysis of different RNA extraction methods
Cecilia Ambrosi et al.
JOURNAL OF VIROLOGICAL METHODS (2021)
Correlations between chest-CT and laboratory parameters in SARS-CoV-2 pneumonia A single-center study from Italy
Antonio Orlacchio et al.
MEDICINE (2021)
Role of MR-proADM in the risk stratification of COVID-19 patients assessed at the triage of the Emergency Department
Marilena Minieri et al.
CRITICAL CARE (2021)
Chest CT in the emergency department for suspected COVID-19 pneumonia
Anna Palmisano et al.
RADIOLOGIA MEDICA (2021)
The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study
Claudia Gregoriano et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Time Course of Lung Changes a Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19 )
Feng Pan et al.
RADIOLOGY (2020)
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
Tao Ai et al.
RADIOLOGY (2020)
How biomarkers can improve pneumonia diagnosis and prognosis: procalcitonin and mid-regional-pro-adrenomedullin
Silvia Spoto et al.
BIOMARKERS IN MEDICINE (2020)
A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias
Dahai Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2
Vincenzo Formica et al.
CLINICAL MEDICINE (2020)
The Three Italy of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia
Carla Prezioso et al.
JOURNAL OF NEUROVIROLOGY (2020)
Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab
Caterina Giannitto et al.
RADIOLOGIA MEDICA (2020)
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis
Nicola Potere et al.
CRITICAL CARE (2020)
Efficacy and accuracy of qSOFA and SOFA scores as prognostic tools for community-acquired and healthcare-associated pneumonia
Nobuhiro Asai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Procalcitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock
Silvia Spoto et al.
MICROBIAL PATHOGENESIS (2019)
The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study
Kordo Saeed et al.
CRITICAL CARE (2019)
Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB
Jacopo Maria Legramante et al.
PLOS ONE (2017)
Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity
David Andaluz-Ojeda et al.
ANNALS OF INTENSIVE CARE (2017)
Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology
Salvador Bello et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Procalcitonin: Uses in the Clinical Laboratory for the Diagnosis of Sepsis
Ming Jin et al.
LABMEDICINE (2010)
Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock
Bettina Temmesfeld-Wollbrueck et al.
INTENSIVE CARE MEDICINE (2007)
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
Mirjam Christ-Crain et al.
CRITICAL CARE (2006)
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2005)
Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index
M Masiá et al.
CHEST (2005)
Hypotensive and natriuretic actions of adrenomedullin in subjects with chronic renal impairment
DO McGregor et al.
HYPERTENSION (2001)
Procalcitonin and C-reactive protein levels in community-acquired pneumonia: Correlation with etiology and prognosis
J Hedlund et al.
INFECTION (2000)
Share Paper
